Latest News & Features
Americas
UK-based Indivior, a company that specialises in addiction treatment drugs, has settled a dispute with generic manufacturer Mylan. 28 September 2017
Big Pharma
The UK’s House of Commons has launched an investigation into post-Brexit regulatory agreements needed to guarantee the safe and effective supply of medicines and medical devices. 27 September 2017
Africa
Interpol has seized more than $51 million worth of potentially dangerous medicines in its latest operation. 27 September 2017
Americas
The Saint Regis Mohawk Tribe has attempted to dismiss inter partes reviews brought by Mylan. 26 September 2017
Americas
Amgen has secured $70 million in damages from a jury in a biosimilar dispute with Hospira. 26 September 2017
Americas
Biopharmaceutical company Gilead has escaped a finding of enhanced damages in its patent dispute with Idenix Pharmaceuticals, a subsidiary of Merck. 25 September 2017
Americas
Japanese drug maker Kowa has won a patent infringement case against Amneal and Apotex over their Abbreviated New Drug Applications. 25 September 2017
Americas
To evaluate how the CRISPR licensing landscape might evolve, parties need to analyse the current patent environment. 22 September 2017
Americas
Innovators in Canada can now enjoy patent term extension for the first time as the Comprehensive Economic and Trade Agreement between the EU and Canada entered into force provisionally today. 21 September 2017
Big Pharma
Recent developments in China’s patent law and practice offer an exciting outlook for the future, said a senior partner at Wanhuida Peksung. 21 September 2017